‘Devices and Drugs of Tomorrow 2002: Prevention and Treatment of Coronary Restenosis’ provides an in-depth, critical evaluation of the key device and drug-based products currently in phase I development and beyond for restenosis. The scope of this report covers the following: * drug-eluting and drug-coated stents * ultrasound therapy * drug therapy * gene therapy * antisense therapy. Analysis in this report is based on material available up to the end of March 2002, including information from the Xxii Annual Congress of the European Society of Cardiology, September 2001, American Heart Association Scientific Sessions, November 2001, and the American College of Cardiology 51st Annual Scientific Session, March 2002. Analysis is supplemented by primary research conducted with opinion leaders in the field of interventional cardiology and medical equipment industry executives.
